Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

Clinical trial NCT03915470 · COMPLETED

Trial details

NCT number: NCT03915470
Sponsor: Destiny Pharma Plc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Staphylococcal Infections Surgical Site Infection

Start date: 2019-08-29
Primary completion: 2021-01-04
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.